Company: LPSN
Filing Date: 2025-10-20
Form Type: 8-K
Source: 0001102993-25-000175
Chunk: 0

Company: LIVEPERSON INC
Filing Date: 2025-10-20
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 14, 2025, the Board of Directors (the “Board”) of LivePerson, Inc. (the “Company”) appointed Ryan L. Vardeman as a Class III director of the Board, with a term expiring as of the Company’s 2027 Annual Meeting of Stockholders. Mr. Vardeman was nominated pursuant to the terms of the previously announced Exchange Agreement, dated August 11, 2025 (the “ Exchange Agreement”), by and among the Company and certain former holders (each, a “ Noteholder”, and collectively, the “ Noteholders”) of the Company’s 0% Senior Convertible Notes due 2026 (the “2026 Notes”), together with thorough review pursuant to the Company’s standard nominating and corporate governance processes. Any committee appointments for Mr. Vardeman will be subsequently disclosed.

Mr. Vardeman serves as a principal of Palogic Value Management, L. P., a Dallas, Texas based investment management company co-founded by Mr. Vardeman in January 2007. Mr. Vardeman has extensive corporate strategy, operating, financial and investment experience including capital structure analysis, with a focus on small-cap equities, and investing in a broad range of industries with an emphasis on technology and software companies. Mr. Vardeman previously served on the board of directors of BSQUARE Corporation from 2018 to 2023 (including serving as the Chairman of the board of directors, Chairman of the Compensation Committee, and a member of the Governance and Nominating Committee), and INTEVAC, Inc. from November 2024 to March 2025. Mr. Vardeman holds a B. S. in Electrical Engineering and Computer Science from Texas Tech University and an M. B. A. from the Owen Graduate School of Management at Vanderbilt University.

Mr. Vardeman will receive standard annual director fees and benefits, as well as an initial grant of equity under the Company’s Amended and Restated 2019 Stock Incentive Plan.

The Company intends to enter into its form of director and executive officer indemnification agreement with Mr. Vardeman, a copy of which has been filed as Exhibit 10.6 to the Company’s Annual Report on Form 10-K filed with the U. S. Securities and Exchange Commission on March 13,